Russell Pachynski

Honored to ring the bell at the start of the business day at the @NYSE along with @MyOncology and friends at @sitcancer

Congrats Alex Tsai and John Lozada for your provocative discovery that immunotherapy sensitivity in cancer may be associated with expansion of CD4+CD8+ (double positive) and NK-like T cells that express TCRs. @UMNews @UMNCancer cell.com/cell-reports-m…

When I left Greece in 2007 pursuing academic career in US, envisioned returning with colleagues from around globe connecting them with Greek colleagues & showing our hospitality! We continue yearly! @tompowles1 @brian_rini @BradMcG04 @bergsa83 @DrOmarMian @ChadTangMD @OncoAlert

An amazing 2 days @sitcancer #biotech discussion @NYSE! We have an amazing community from VC, banks, pharma, small co's, academia & more. Biotech has some heavy demands yet it is an outstanding & fortunate opportunity to be able to contribute at @StrandTx amongst these colleagues

well, thats a good news for us "It is my pleasure to inform you that #United #States #Patent No. 12,636,317 issued on May 26, 2026" ->"Manipulation and Use of Antigen-Specific Regulatory T Cells"

Today, on my birthday, I am overwhelmed with gratitude for my family, friends, colleagues and the privilege of doing science and caring for patients. One of the best gifts I received today was seeing the fruits of mentorship: not one, but TWO members of the Faltas Lab, Rahul Singh PhD. and Jaekwon Kim MD, PhD, received $100K Young Investigator Awards. Congratulations, Rahul and Jaekwon, on your hard work, persistence, and success. Proud and grateful to be part of your journey! It took us a few tries to spell out YIA, but we managed in the end :) #TeamScience #Mentorship

An important study that highlights the complexity of using PSMA PET as an endpoint. Prognostic significance of PSMA tumor volume varied between patients with low and high volume of disease (*particularly relevant for #PSMA+BCR):